{
    "2018-07-31": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：重点推荐低估值高成长龙头仁和药业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "低估值",
                        "高成长",
                        "仁和药业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中金医药月度7+5组合：8月组合",
                "features": {
                    "keywords": [
                        "中金医药",
                        "月度组合",
                        "8月"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "快讯：两桶油发力 上证50指数快速翻红",
                "features": {
                    "keywords": [
                        "两桶油",
                        "上证50",
                        "翻红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "能源",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "权重股上攻 上证50翻红",
                "features": {
                    "keywords": [
                        "权重股",
                        "上证50",
                        "翻红"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：5家药企的缬沙坦致癌物超出限值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "缬沙坦",
                        "致癌物",
                        "超标"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "广东大范围下调抗癌药价格 上市药企迎“以价换量”机会",
                "features": {
                    "keywords": [
                        "广东",
                        "抗癌药",
                        "价格下调",
                        "以价换量"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:药物临床试验审评审批实施到期默认制,政策东风持续鼓励新药研发",
                "features": {
                    "keywords": [
                        "医药生物",
                        "临床试验",
                        "审评审批",
                        "默认制",
                        "政策",
                        "新药研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}